Odyssey Health (ODYY) Net Cash Flow (2014 - 2026)
Odyssey Health's (ODYY) quarterly Net Cash Flow came in at -$318521.0 in Q2 2026, down 7861.03% year-on-year from $4104.1 in Q2 2025, and down 153.92% quarter-over-quarter from $590741.0 in Q1 2026.
Odyssey Health (ODYY) Net Cash Flow (2014 - 2026) Analysis & Trends
Odyssey Health's Net Cash Flow history runs 13 years deep, the most recent figure standing at -$318521.0 for Q2 2026.
- On a quarterly basis, Net Cash Flow fell 7861.03% year-over-year to -$318521.0 in Q2 2026; TTM through Apr 2026 was $294620.0, a 568.93% increase from a year earlier, with the FY2025 full-year figure at $16705.0, up 148.44% from the prior year.
- Net Cash Flow fell to -$318521.0 in Q2 2026 per ODYY's latest filing, from $590741.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $590741.0 in Q1 2026 and bottomed at -$339803.0 in Q1 2022.
- The 5-year median for Net Cash Flow is -$9354.0 (2023), against an average of $13327.1.
- Biggest YoY gain for Net Cash Flow was 1365.57% in 2026; the steepest drop was 7861.03% in 2026.
- Year by year, Net Cash Flow stood at -$22035.0 in 2022, then jumped by 830.73% to $161017.0 in 2023, then slumped by 68.02% to $51486.0 in 2024, then sank by 87.37% to $6502.0 in 2025, then sank by 4998.82% to -$318521.0 in 2026.
- Per Business Quant, the three latest ODYY Net Cash Flow figures stand at -$318521.0 (Q2 2026), $590741.0 (Q1 2026), and $6502.0 (Q4 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | -318,521.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -318,521.00 |
| Apr 30, 2026 | -318,521.00 |
| Jan 31, 2026 | 590,741.00 |
| Jan 31, 2026 | 590,741.00 |
| Oct 31, 2025 | 6,502.00 |
| Oct 31, 2025 | 6,502.00 |
| Jul 31, 2025 | 15,898.00 |
| Jul 31, 2025 | 15,898.00 |
| Apr 30, 2025 | -4,001.00 |
| Apr 30, 2025 | -4,001.00 |
| Jan 31, 2025 | -46,678.00 |
| Jan 31, 2025 | -46,678.00 |
| Oct 31, 2024 | 51,486.00 |
| Oct 31, 2024 | 51,486.00 |
| Jul 31, 2024 | -63,635.00 |
| Jul 31, 2024 | -63,635.00 |
| Apr 30, 2024 | -100,126.00 |
| Apr 30, 2024 | -100,126.00 |
| Jan 31, 2024 | -31,742.00 |
| Jan 31, 2024 | -31,742.00 |